Superlatus Foods, Inc. acquired Superlatus, Inc from TRxADE HEALTH, Inc. for $1.
March 05, 2024
Share
Superlatus Foods, Inc. acquired Superlatus, Inc from TRxADE HEALTH, Inc. (NasdaqCM:MEDS) for $1 on March 5, 2024. Andy Tucker of Nelson Mullins Riley & Scarborough LLP acted as legal advisor to TRxADE HEALTH, Inc.
Superlatus Foods, Inc. completed the acquisition of Superlatus, Inc from TRxADE HEALTH, Inc. (NasdaqCM:MEDS) on March 5, 2024.
TRxADE Health, Inc. provides a technology-enabled health services platform. The Company is focused on digitalizing the retail pharmacy and health services experience by optimizing drug procurement, the prescription journey, access to physicians in the patientâs home and patient engagement in the United States. The Companyâs segments include Trxade, Inc., Integra Pharma Solutions, LLC (IPS) and Superlatus. Trxade, Inc. segment provides a web-based pharmaceutical marketplace platform-business to business (B2B) sales. IPS is a licensed pharmaceutical wholesaler and sells brand, generic and non-drug products to customers. The Superlatus segment holds Sapientiaâs intellectual property for advanced food extrusion technology and The Urgent Company, which is a manufacturer of ice cream that is animal product-free, vegan, lactose-free, and made with plant-B2B sales. Its subsidiaries include Community Specialty Pharmacy, LLC, Alliance Pharma Solutions, LLC, Bonum Health, LLC and others.
TRXADE HEALTH, INC. 
